Molecular Diagnosis of Myotonic Dystrophy

Sujata Chakraborty; Matteo Vatta; Linda L Bachinski; Ralf Krahe; Stephen Dlouhy; Shaochun Bai

doi:10.1002/cphg.22

Molecular Diagnosis of Myotonic Dystrophy

Curr Protoc Hum Genet. 2016 Oct 11;91:9.29.1-9.29.19. doi: 10.1002/cphg.22.

Authors

Sujata Chakraborty¹, Matteo Vatta¹, Linda L Bachinski², Ralf Krahe², Stephen Dlouhy¹, Shaochun Bai¹

Affiliations

¹ Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana.
² Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas.

PMID: 27727437
DOI: 10.1002/cphg.22

Abstract

Myotonic dystrophy types 1 (DM1) and 2 (DM2) are autosomal dominant, microsatellite repeat expansion disorders that affect muscle function. Myotonic dystrophy type 1 is caused by CTG repeat expansion in the 3' UTR region of the DMPK gene. Patients with DM2 have expansion of CCTG repeats in intron 1 of the CNBP gene. In this unit, we review and discuss the clinical phenotypes, genetic mutations causing the diseases, and the molecular diagnostic approaches and tools that are used to determine repeat sizes in DM1/2. In summary, the goal of this chapter is to provide the reader with a basic understanding of the clinical, genetic and diagnostic aspects of these disorders. © 2016 by John Wiley & Sons, Inc.

Keywords: CCTG repeat; CNBP; CTG repeat; DMPK; Myotonic dystrophy type 2; Southern Blot; myotonic dystrophy type 1; repeat-primed PCR (RP-PCR); triplet-repeat primed PCR (TP-PCR).

MeSH terms

Humans
Mutation / genetics*
Myotonic Dystrophy / diagnosis*
Myotonic Dystrophy / genetics*
Pathology, Molecular / methods*
Phenotype
Trinucleotide Repeat Expansion / genetics*

Grants and funding

R01 AR048171/AR/NIAMS NIH HHS/United States